CMC and regulatory considerations for polyethylene glycol-modified protein therapeutics
スポンサーリンク
概要
- 論文の詳細を見る
- 2005-11-10
著者
-
Wylie Susan
Department Of Biotechnology Development Schering Plough Research Institute
-
KLINE Doug
Department of Pharmaceutical Development, Schering Plough Research Institute
-
INLOES Doug
Department of Biotechnology Development, Schering Plough Research Institute
-
Kline Doug
Department Of Pharmaceutical Development Schering Plough Research Institute
-
Inloes Doug
Department Of Biotechnology Development Schering Plough Research Institute